Patient perspectives on testing for clonal hematopoiesis of indeterminate potential
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022008376
Abstract: Key Points • Many young breast cancer survivors are interested in CHIP testing, with preferences varying by risk communication and actionability.• Learning of CHIP and its associated risks may elicit significant anxiety, requiring provider awareness… read more here.
Keywords: perspectives testing; testing clonal; indeterminate potential; hematopoiesis indeterminate ... See more keywords